<DOC>
	<DOCNO>NCT02350751</DOCNO>
	<brief_summary>The purpose study evaluate safety pharmacokinetics MEDI8852 compare placebo administer healthy adult subject .</brief_summary>
	<brief_title>Phase 1 Placebo-controlled , Dose-escalation Study Evaluate Safety Pharmacokinetics MEDI8852 Adults</brief_title>
	<detailed_description>This phase 1 , single-dose , double-blind , placebo-controlled , dose-escalation study evaluate safety pharmacokinetics MEDI8852 compare placebo administer healthy adult subject . Approximately 40 subject enter receive treatment across 4 fix dose cohort 1 site . Investigational product deliver intravenously ( IV ) . A total 4 different dose level investigational product evaluate across cohort . Subjects follow approximately 100 day .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>1 . Age 18 65 year time screen 2 . Weight ≥ 45 kg ≤ 110 kg screen 3 . Healthy medical history , physical examination , baseline safety laboratory study . 4 . Systolic blood pressure ( BP ) &lt; 140 mm Hg diastolic BP &lt; 90 mm Hg screen 5 . Electrocardiogram without clinically significant abnormality screen 6 . Able complete followup period Day 101 require protocol 7 . Females childbearing potential sexually active nonsterilized male partner must use highly effective method contraception least 28 day prior first dose investigational product must agree continue use precaution Day 101 study 1 . Acute illness , include fever &gt; 99.5°F , day prior day plan dose 2 . Any drug therapy within 7 day prior Day 1 ( except contraceptive single use acetaminophen , aspirin , antihistamine . nutritional supplement take least 30 day prior enrollment , exclusionary . 3 . Blood drawn excess total 450 mL ( 1 unit ) reason within 2 month prior screen 4 . Receipt immunoglobulin blood product within 6 month prior screen 5 . Receipt vaccine within 14 day prior investigational product dosing plan receipt influenza vaccine within 100 day investigational product dose 6 . Either history active infection hepatitis B C positive test hepatitis C hepatitis B surface antigen screen 7 . Aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) , serum creatinine upper limit normal hemoglobin , white blood cell count , platelet count lower limit normal screen 8 . History malignancy treat nonmelanoma skin cancer locallytreated cervical cancer previous 5 year 9 . Pregnant nursing mother 10 . History alcohol drug abuse within past 2 year tha OR positive Class A drug screen amphetamine , barbiturate , opiate , cocaine screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Influenza , Flu , Flu A , Influenza A</keyword>
</DOC>